Go Pro

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Short Interest Update

Neuberger Berman High Yield Strategies Fund logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Short interest plunged in Neuberger Berman High Yield Strategies Fund, falling 73.5% to 12,601 shares as of June 30 from 47,607 shares two weeks earlier. That leaves roughly 0.0% of shares sold short.
  • The fund’s shares were up 0.3% to $6.23 on Friday, trading below both its 50-day moving average of $6.29 and 200-day moving average of $6.84. The stock remains near its 52-week low of $6.06.
  • NHS announced a monthly dividend of $0.0905 per share, payable July 31 to shareholders of record on July 15, implying an annualized yield of about 17.4%.
  • Five stocks we like better than Neuberger Berman High Yield Strategies Fund.

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS - Get Free Report) was the target of a large drop in short interest in the month of June. As of June 30th, there was short interest totaling 12,601 shares, a drop of 73.5% from the June 15th total of 47,607 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 336,404 shares, the days-to-cover ratio is currently 0.0 days.

Neuberger Berman High Yield Strategies Fund Stock Up 0.3%

Shares of NYSEAMERICAN:NHS traded up $0.02 on Friday, hitting $6.23. The stock had a trading volume of 139,218 shares, compared to its average volume of 228,654. Neuberger Berman High Yield Strategies Fund has a twelve month low of $6.06 and a twelve month high of $7.75. The firm's 50 day moving average price is $6.29 and its 200-day moving average price is $6.84.

Neuberger Berman High Yield Strategies Fund Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, July 31st. Investors of record on Wednesday, July 15th will be issued a $0.0905 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 17.4%. The ex-dividend date of this dividend is Wednesday, July 15th.

Institutional Investors Weigh In On Neuberger Berman High Yield Strategies Fund

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Guggenheim Capital LLC boosted its stake in shares of Neuberger Berman High Yield Strategies Fund by 38.0% in the 4th quarter. Guggenheim Capital LLC now owns 567,943 shares of the investment management company's stock valued at $4,225,000 after purchasing an additional 156,386 shares during the last quarter. GraniteShares Advisors LLC bought a new position in Neuberger Berman High Yield Strategies Fund during the fourth quarter worth about $2,832,000. Invesco Ltd. grew its position in shares of Neuberger Berman High Yield Strategies Fund by 3.5% during the 2nd quarter. Invesco Ltd. now owns 258,944 shares of the investment management company's stock worth $1,963,000 after buying an additional 8,676 shares during the period. Ameriprise Financial Inc. grew its position in shares of Neuberger Berman High Yield Strategies Fund by 47.4% during the 3rd quarter. Ameriprise Financial Inc. now owns 117,760 shares of the investment management company's stock worth $883,000 after buying an additional 37,860 shares during the period. Finally, Harbour Investments Inc. increased its stake in shares of Neuberger Berman High Yield Strategies Fund by 3.7% in the 4th quarter. Harbour Investments Inc. now owns 109,642 shares of the investment management company's stock valued at $816,000 after acquiring an additional 3,930 shares during the last quarter.

Neuberger Berman High Yield Strategies Fund Company Profile

(Get Free Report)

The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.

Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Neuberger Berman High Yield Strategies Fund Right Now?

Before you consider Neuberger Berman High Yield Strategies Fund, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neuberger Berman High Yield Strategies Fund wasn't on the list.

While Neuberger Berman High Yield Strategies Fund currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines